adult

Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients

MIAMI, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company…

3 months ago

Immunity and Intellect: Manipal Hospital Hebbal Champions Senior Health with Spell Bee Competition and Adult Vaccination Awareness

BENGALURU, India, June 25, 2025 /PRNewswire/ -- India is now experiencing a rise in the proportion of elderly individuals, thanks to…

5 months ago